Literature DB >> 15629999

Lactobacillus sepsis associated with probiotic therapy.

Michael H Land1, Kelly Rouster-Stevens, Charles R Woods, Michael L Cannon, James Cnota, Avinash K Shetty.   

Abstract

Probiotic strains of lactobacilli are increasingly being used in clinical practice because of their many health benefits. Infections associated with probiotic strains of lactobacilli are extremely rare. We describe 2 patients who received probiotic lactobacilli and subsequently developed bacteremia and sepsis attributable to Lactobacillus species. Molecular DNA fingerprinting analysis showed that the Lactobacillus strain isolated from blood samples was indistinguishable from the probiotic strain ingested by the patients. This report indicates, for the first time, that invasive disease can be associated with probiotic lactobacilli. This report should not discourage the appropriate use of Lactobacillus or other probiotic agents but should serve as a reminder that these agents can cause invasive disease in certain populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629999     DOI: 10.1542/peds.2004-2137

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  128 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

Review 2.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

3.  Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice.

Authors:  Qi Liu; Yunhuan Liu; Fengyuan Li; Zelin Gu; Min Liu; Tuo Shao; Lihua Zhang; Guangyao Zhou; Chengwei Pan; Liqing He; Jun Cai; Xiang Zhang; Shirish Barve; Craig J McClain; Yiping Chen; Wenke Feng
Journal:  J Nutr Biochem       Date:  2019-10-24       Impact factor: 6.048

4.  Use of probiotics in gastrointestinal disorders: what to recommend?

Authors:  Elizabeth C Verna; Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

Review 5.  Safety of probiotics: comparison of two popular strains.

Authors:  Cathy Hammerman; Alona Bin-Nun; Michael Kaplan
Journal:  BMJ       Date:  2006-11-11

6.  Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

Authors:  P Marteau; M Lémann; P Seksik; D Laharie; J F Colombel; Y Bouhnik; G Cadiot; J C Soulé; A Bourreille; E Metman; E Lerebours; F Carbonnel; J L Dupas; M Veyrac; B Coffin; J Moreau; V Abitbol; S Blum-Sperisen; J Y Mary
Journal:  Gut       Date:  2005-12-23       Impact factor: 23.059

7.  Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury.

Authors:  Yuhua Wang; Yanlong Liu; Anju Sidhu; Zhenhua Ma; Craig McClain; Wenke Feng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-26       Impact factor: 4.052

8.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; Robert Whitehead; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

9.  A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor.

Authors:  Fang Yan; Liping Liu; Peter J Dempsey; Yu-Hwai Tsai; Elaine W Raines; Carole L Wilson; Hailong Cao; Zheng Cao; LinShu Liu; D Brent Polk
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

10.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.